Warning! GuruFocus detected
1 Severe warning sign
with PROF.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Profound Medical Corp
NAICS : 621511
SIC : 8689
ISIN : CA74319B1067
Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.72 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.59 | |||||
| Beneish M-Score | -2.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.6 | |||||
| 3-Year EBITDA Growth Rate | -1 | |||||
| 3-Year EPS without NRI Growth Rate | 1.9 | |||||
| 3-Year FCF Growth Rate | 2.1 | |||||
| 3-Year Book Growth Rate | -16.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 80.72 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.21 | |||||
| 9-Day RSI | 39.46 | |||||
| 14-Day RSI | 43.57 | |||||
| 3-1 Month Momentum % | 1.72 | |||||
| 6-1 Month Momentum % | -4.95 | |||||
| 12-1 Month Momentum % | -12.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.52 | |||||
| Quick Ratio | 9.64 | |||||
| Cash Ratio | 8.36 | |||||
| Days Inventory | 653.08 | |||||
| Days Sales Outstanding | 232.51 | |||||
| Days Payable | 220.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.1 | |||||
| Shareholder Yield % | -29.59 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.98 | |||||
| Operating Margin % | -307.47 | |||||
| Net Margin % | -257.73 | |||||
| FCF Margin % | -219.6 | |||||
| ROE % | -66.68 | |||||
| ROA % | -52.59 | |||||
| ROIC % | -250.48 | |||||
| 3-Year ROIIC % | 223.65 | |||||
| ROC (Joel Greenblatt) % | -286.43 | |||||
| ROCE % | -72.45 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 16.24 | |||||
| PB Ratio | 3.36 | |||||
| Price-to-Tangible-Book | 3.37 | |||||
| EV-to-EBIT | -4.48 | |||||
| EV-to-EBITDA | -4.61 | |||||
| EV-to-Revenue | 13.86 | |||||
| EV-to-Forward-Revenue | 8.11 | |||||
| EV-to-FCF | -6.8 | |||||
| Price-to-GF-Value | 0.61 | |||||
| Price-to-Net-Current-Asset-Value | 3.43 | |||||
| Price-to-Net-Cash | 4.48 | |||||
| Earnings Yield (Greenblatt) % | -22.32 | |||||
| FCF Yield % | -11.85 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PROF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Profound Medical Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10.68 | ||
| EPS (TTM) ($) | -1.13 | ||
| Beta | 0.6 | ||
| 3-Year Sharpe Ratio | 0.17 | ||
| 3-Year Sortino Ratio | 0.35 | ||
| Volatility % | 45.95 | ||
| 14-Day RSI | 43.57 | ||
| 14-Day ATR ($) | 0.411649 | ||
| 20-Day SMA ($) | 6.96625 | ||
| 12-1 Month Momentum % | -12.45 | ||
| 52-Week Range ($) | 5.63 - 11.42 | ||
| Shares Outstanding (Mil) | 30.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Profound Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Profound Medical Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Profound Medical Corp Frequently Asked Questions
What is Profound Medical Corp(PROF)'s stock price today?
The current price of PROF is $6.68. The 52 week high of PROF is $11.42 and 52 week low is $5.63.
When is next earnings date of Profound Medical Corp(PROF)?
The next earnings date of Profound Medical Corp(PROF) is 2025-05-09 Est..
Does Profound Medical Corp(PROF) pay dividends? If so, how much?
Profound Medical Corp(PROF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers